Advanced Filters
noise

Birth Control Clinical Trials

A listing of Birth Control medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 5 clinical trials
A Alex Dawes

Botulinum Toxin in Raynaud's Phenomenon

Raynaud's Phenomenon (RP) is the most common vasospastic disorder encountered by hand surgeons with an estimated prevalence of 5% in the general population. It's manifestations are broad, and can range from minor to severe. Sometimes it can be refractory to treatments. The goal of this study is to evaluate the …

18 - 100 years of age Both Phase 4
P PETER KORSTEN

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

In this feasibility study, we aim to explore therapeutic Rheopheresis (RheoP) as a novel treatment option for SSc-associated Raynaud's phenomenon and/or digital ulcers and compare it to the standard of care treatment (intravenous iloprost. RheoP has been used for RP/DU with some success in observational studies, nevertheless, the optimal treatment …

18 - 100 years of age Both Phase N/A
D Douwe J Mulder, MD, PhD

Follow-up of SPTS in Patients With Raynaud's Phenomenon

Background: Raynaud's phenomenon is a vasospasm of the extremities, leading to extensive discomfort in daily life and potentially severe ischemia. Some patients are resistant to conventional vasodilatory drug treatment. In the University Medical Center Groningen, single-port thoracoscopic sympathicotomy (SPTS) was developed. This is a new minimally invasive endoscopic technique, extensively …

16 - 100 years of age Both Phase N/A
M Matthieu Roustit

Application for Monitoring and Evaluation of Raynaud's Phenomenon

To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.

18 - 75 years of age Both Phase N/A
E Emmanuel CHATELUS, MD

Metabolomic Analysis of Systemic Sclerosis

Currently investigators do not have diagnostic and prognostic markers for SSc which almost always starts with a vascular disease (Raynaud's disease) isolated for several years. The primary purpose is to highlight discriminating metabolic profiles depending on the characteristics of the disease, allowing early diagnosis of SSc at the onset of …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI